CORRECTION article

Front. Cell Dev. Biol., 07 March 2022

Sec. Molecular and Cellular Pathology

Volume 10 - 2022 | https://doi.org/10.3389/fcell.2022.843275

Corrigendum: The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers

  • 1. School of Laboratory Medicine, Hangzhou Medical College, Hangzhou, China

  • 2. Southern Marine Science and Engineering Guangdong Laboratory (Zhanjiang), Guangdong Medical University, Zhanjiang, China

  • 3. Guangdong Provincial Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital (Shenzhen Institute of Translational Medicine), Shenzhen, China

  • 4. Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Article metrics

View details

1

Citations

1,1k

Views

615

Downloads

In the published article, there was an error in affiliation 1. Instead of “Anhui Clinical and Preclinical Key Laboratory of Respiratory Disease, Department of Respiratory Disease, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China”, it should be “School of Laboratory Medicine, Hangzhou Medical College, Hangzhou, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

lung cancer, N6-methyladenosine, prognosis, regulators, risk scores

Citation

Tan S, Li Z, Li K, Li Y, Liang G, Tang Z, Kang J, Chen W, Li M, Zou Z, Pi G and Zhu X (2022) Corrigendum: The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers. Front. Cell Dev. Biol. 10:843275. doi: 10.3389/fcell.2022.843275

Received

25 December 2021

Accepted

27 January 2022

Published

07 March 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

10 - 2022

Updates

Copyright

*Correspondence: Guoliang Pi, ; Xiao Zhu,

†These authors have contributed equally to this work

This article was submitted to Molecular and Cellular Pathology, a section of the journal Frontiers in Cell and Developmental Biology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics